Riskpilot← Back to searchSign inGet full accessSista versen 81968 AB
ABDissolvedOrg 5566677042Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20041 employees
Revenue 2022
SEK 59K
-65% vs 2021
EBITDA margin
22.0%
-82% vs 2021
Equity ratio
84.5%
Financial strength
Net profit 2022
SEK 36K
-45% vs 2021
| Revenue | SEK 59K | -65% |
| EBITDA | SEK 13K | -82% |
| Net profit | SEK 36K | -45% |
| Total assets | SEK 317K | -37% |
| Equity | SEK 268K | -36% |
| Employees | 1 | — |
Legal name
Sista versen 81968 AB
Org number
5566677042
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
5 oktober 2004
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 943 | 496 | 91 | 167 | 59 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −67 | −100 | −57 | 71 | 13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −67 | −100 | −57 | 71 | 13 |
| Net financials | — | — | — | — | — |
| Profit before tax | 76 | 65 | 1 | 84 | 46 |
| Tax | −17 | −16 | −1 | −18 | −10 |
| Net profit | 59 | 49 | 0 | 66 | 36 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1 188 | 873 | 633 | 501 | 317 |
| Equity | 836 | 713 | 536 | 419 | 268 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 58 | 31 | 26 | 23 | 24 |
| Total debt | 58 | 31 | 26 | 23 | 24 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20182022
Equity ratio
84.5%
This company
38.2%
Market median
+121% vs market
20182022
Return on equity
13.4%
This company
18.4%
Market median
+27% vs market
20182022
Net profit margin
61.0%
This company
8.1%
Market median
+653% vs market
20182022
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20182022
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2022 – 2024 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sista versen 81968 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Axel Johansson Gren | Audit | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |